These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32001728)

  • 1. Analysis of Plasmodium falciparum Rh2b deletion polymorphism across different transmission areas.
    Aniweh Y; Suurbaar J; Morang'a CM; Nyarko PB; Wright KE; Kusi KA; Ansah F; Kyei-Baafour E; Quansah E; Asante J; Thiam LG; Higgins MK; Awandare GA
    Sci Rep; 2020 Jan; 10(1):1498. PubMed ID: 32001728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Plasmodium falciparum erythrocyte binding protein associated with the merozoite surface, PfDBLMSP.
    Wickramarachchi T; Cabrera AL; Sinha D; Dhawan S; Chandran T; Devi YS; Kono M; Spielmann T; Gilberger TW; Chauhan VS; Mohmmed A
    Int J Parasitol; 2009 Jun; 39(7):763-73. PubMed ID: 19367830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru.
    Villasis E; Lopez-Perez M; Torres K; Gamboa D; Neyra V; Bendezu J; Tricoche N; Lobo C; Vinetz JM; Lustigman S
    Malar J; 2012 Oct; 11():361. PubMed ID: 23110555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes.
    Mwakalinga SB; Wang CW; Bengtsson DC; Turner L; Dinko B; Lusingu JP; Arnot DE; Sutherland CJ; Theander TG; Lavstsen T
    Malar J; 2012 Dec; 11():429. PubMed ID: 23259643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Erythrocyte Invasion Mechanisms of Plasmodium falciparum Clinical Isolates Across 3 Malaria-Endemic Areas in Ghana.
    Mensah-Brown HE; Amoako N; Abugri J; Stewart LB; Agongo G; Dickson EK; Ofori MF; Stoute JA; Conway DJ; Awandare GA
    J Infect Dis; 2015 Oct; 212(8):1288-97. PubMed ID: 25838264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.
    Ahouidi AD; Bei AK; Neafsey DE; Sarr O; Volkman S; Milner D; Cox-Singh J; Ferreira MU; Ndir O; Premji Z; Mboup S; Duraisingh MT
    Infect Genet Evol; 2010 Mar; 10(2):200-6. PubMed ID: 19931645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections.
    Abdel-Latif MS; Khattab A; Lindenthal C; Kremsner PG; Klinkert MQ
    Infect Immun; 2002 Dec; 70(12):7013-21. PubMed ID: 12438381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria.
    Reiling L; Richards JS; Fowkes FJ; Barry AE; Triglia T; Chokejindachai W; Michon P; Tavul L; Siba PM; Cowman AF; Mueller I; Beeson JG
    J Immunol; 2010 Nov; 185(10):6157-67. PubMed ID: 20962255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of erythrocyte invasion in Plasmodium falciparum isolates from Senegal.
    Jennings CV; Ahouidi AD; Zilversmit M; Bei AK; Rayner J; Sarr O; Ndir O; Wirth DF; Mboup S; Duraisingh MT
    Infect Immun; 2007 Jul; 75(7):3531-8. PubMed ID: 17470537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in the expression of a Plasmodium falciparum protein family implicated in erythrocyte invasion.
    Taylor HM; Grainger M; Holder AA
    Infect Immun; 2002 Oct; 70(10):5779-89. PubMed ID: 12228308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
    Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
    Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domains.
    Triglia T; Chen L; Lopaticki S; Dekiwadia C; Riglar DT; Hodder AN; Ralph SA; Baum J; Cowman AF
    PLoS Pathog; 2011 Jun; 7(6):e1002075. PubMed ID: 21698217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
    Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
    PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175.
    Liang H; Sim BK
    Mol Biochem Parasitol; 1997 Feb; 84(2):241-5. PubMed ID: 9084043
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.